Northwestern to co-lead immunotherapy drug trial for rare cancers – Chicago Tribune
Chicago Tribune |
Northwestern to co-lead immunotherapy drug trial for rare cancers
Chicago Tribune Dr. Frank Giles, chief of hematology and oncology at Northwestern University's Feinberg School of Medicine, is photographed Jan. 16, 2017, at Northwestern's Chicago medical campus. Giles is one of four principal investigators in a new immunotherapy … SWOG launches national immunotherapy clinical trial for rare cancers |
